Research article · 2015
Conference abstract
Co-factor augmented anaphylaxis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Anaphylaxis is an acute, life-threatening, systemic reaction caused by mediators released from different cells. The underlying mechanisms of anaphylaxis can be several with the key players being specific IgE, mast cells, and basophils. Co-factors are factors which when present during anaphylaxis makes the anaphylaxis possible, or more severe. The Augmenting factors like exercise, alcohol, infections, antacids and menstrual cycle; the concomitant diseases like asthma, mastocytosis and cardiac disease and cofactors like allergens, betablockers can be risk factors for anaphylaxis. The other major risk factors for severe anaphylaxis might be age, sex, pre-existing medical conditions and antihypertensive drugs. Other than cofactors; mediators, pathways and cell types can also serve as factors for anaphylaxis. Human anaphylaxis can be generally classified as immunologic, non-immunologic and idiopathic. The classification is based on factors and causes. The talk covers some examples of known cofactors for anaphylaxis and also the prevalence of co-factor augment anaphylaxis. Certain cases studies on wheat-dependent exercise induced anaphylaxis, co-factor associated anaphylaxis and LTP Syndrome will be covered.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Case report · 2014
Non-Steroidal Anti-Inflammatory Drug Ingestion as a Risk Factor to Anaphylaxis During Immunotherapy: a Case Series
Conference abstract · 2 Oct 2017
Enhancement of cyanobacterial ethanol production by co-factor engineering
Conference abstract · 26 Oct 2015
Superiority through selectivity: Unnatural co-factors and the enzymes that bind them
Conference abstract · 31 Aug 2015
cMyc and its new viral co-factor kaposin B modulate endothelial cell non-coding RNA traits to elicit angiogenesis
More from this journal
The newest in Journal of Allergy & Therapy.
Article · 29 Jun 2026
Allergy Diagnostics Innovation: Advancing Precision Identification of Immune Responses
Article · 29 Jun 2026
Immunomodulatory Therapeutics: Advancing Immune System Control Through Targeted Medical Strategies
Article · 29 Jun 2026
Immunoglobulin E (IgE) Regulation: Understanding Molecular Control of Allergic Immune Responses
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Allergy & Therapy
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Vincent St Aubyn Crump”

